Enhancement of lipopolysaccharide-stimulated cyclooxygenase-2 mRNA expression and prostaglandin E2 production in gingival fibroblasts from individuals with Down syndrome

[1]  T. Nishihara,et al.  Involvement of prostaglandin E2 and interleukin-1 alpha in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4. , 2010, Journal of periodontal research.

[2]  Y. Abiko,et al.  Effect of in vitro aging on Campylobacter rectus lipopolysaccharide-stimulated PGE2 release from human gingival fibroblasts. , 2008, Oral diseases.

[3]  W. Weston,et al.  Phagocytic function in Down syndrome--II. Bactericidal activity and phagocytosis. , 2008, Journal of mental deficiency research.

[4]  W. Weston,et al.  Phagocytic function in Down syndrome--I. Chemotaxis. , 2008, Journal of mental deficiency research.

[5]  J. Swallow.  DENTAL DISEASE IN CHILDREN WITH DOWN'S SYNDROME. , 2008, Journal of mental deficiency research.

[6]  G. Pistritto,et al.  Bacterial lipopolysaccharide increases prostaglandin production by rat astrocytes via inducible cyclo-oxygenase: evidence for the involvement of nuclear factor kappaB. , 1999, Biochemical and biophysical research communications.

[7]  P. Engström,et al.  Periodontal conditions and salivary immunoglobulins in individuals with Down syndrome. , 1998, Journal of periodontology.

[8]  P. Cichoń,et al.  Early-onset periodontitis associated with Down's syndrome--clinical interventional study. , 1998, Annals of periodontology.

[9]  H. Kawaguchi,et al.  Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation. , 1997, Endocrinology.

[10]  T. Modéer,et al.  Prostaglandin E2 level in gingival crevicular fluid from patients with Down syndrome. , 1997, Acta odontologica Scandinavica.

[11]  L. Shapira,et al.  Prostaglandin E2 secretion, cell maturation, and CD14 expression by monocyte-derived macrophages from localized juvenile periodontitis patients. , 1996, Journal of periodontology.

[12]  P. Casamassimo,et al.  Serum antibody response to Actinobacillus actinomycetemcomitans in Down's syndrome. , 1996, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[13]  B. Burt.  Periodontitis and aging: reviewing recent evidence. , 1994, Journal of the American Dental Association.

[14]  M. Schweiger,et al.  Correlation between senescence and DNA repair in cells from young and old individuals and in premature aging syndromes. , 1994, Mutation research.

[15]  A. Ford-hutchinson,et al.  Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues , 1993, FEBS letters.

[16]  S. Offenbacher,et al.  Modulation of Host PGE2 Secretion as a Determinant of Periodontal Disease Expression. , 1993, Journal of periodontology.

[17]  T. Modéer,et al.  Actinobacillus actinomycetemcomitans, Capnocytophaga and Porphyromonas gingivalis in subgingival plaque of adolescents with Down's syndrome. , 1992, Oral microbiology and immunology.

[18]  N. Ijuhin,et al.  Effect of exogenously applied prostaglandin E2 on alveolar bone loss--histometric analysis. , 1992, Journal of periodontology.

[19]  H R Herschman,et al.  Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. , 1992, The Journal of biological chemistry.

[20]  D. Dewitt,et al.  Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences. , 1992, Archives of biochemistry and biophysics.

[21]  H. J. Sismey-Durrant,et al.  Effect of lipopolysaccharide from Porphyromonas gingivalis on prostaglandin E2 and interleukin-1-beta release from rat periosteal and human gingival fibroblasts in vitro. , 1991, Oral microbiology and immunology.

[22]  P. Sloper,et al.  Health problems in children with Down's syndrome. , 1990, Child: care, health and development.

[23]  H. Kiyak,et al.  Aging or disease? Periodontal changes and treatment considerations in the older dental patient. , 1989, Gerodontology.

[24]  Y. Izumi,et al.  Defective neutrophil chemotaxis in Down's syndrome patients and its relationship to periodontal destruction. , 1989, Journal of periodontology.

[25]  J. Nw.  Detection of high-risk groups and individuals for periodontal diseases. , 1989 .

[26]  S. Holt,et al.  Lipopolysaccharide-Stimulated PGE2 Release from Human Monocytes , 1988 .

[27]  J. S. van de Gevel,et al.  Nonspecific and specific immune responses in a child with Down's syndrome and her sibling. A case report. , 1988, Journal of periodontology.

[28]  M. Listgarten,et al.  Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. , 1988, Journal of clinical periodontology.

[29]  G. R. Imm,et al.  A Comparative Study of Human Periodontal Ligament Cells and Gingival Fibroblasts in vitro , 1988, Journal of dental research.

[30]  S. Poppema,et al.  Experimental gingivitis in a Down's syndrome child and sibling , 1987, Journal of clinical microbiology.

[31]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[32]  L. T. van der Weele,et al.  Experimental gingivitis around deciduous teeth in children with Down's syndrome. , 1986, Journal of clinical periodontology.

[33]  S. Hamada,et al.  Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli , 1985, Infection and immunity.

[34]  U. Velden.  Effect of age on the periodontium , 1984 .

[35]  R. Page.  Periodontal Diseases in the Elderly: A Critical Evaluation of Current Information1 , 1984 .

[36]  J. Slots,et al.  Actinobacillus actinomycetemcomitans in human periodontal disease. Prevalence in patient groups and distribution of biotypes and serotypes within families. , 1983, Journal of periodontology.

[37]  A. Khan,et al.  Defective neutrophil chemotaxis in patients with Down syndrome. , 1975, The Journal of pediatrics.

[38]  F. Dewhirst,et al.  Prostaglandin E2 levels and human periodontal disease. , 1974, Prostaglandins.

[39]  D. Segal,et al.  Studies on Down's syndrome in tissue culture. I. Growth rates protein contents of fibroblast cultures , 1974, Journal of cellular physiology.

[40]  V. Cristofalo,et al.  Cellular senescence and DNA synthesis. Thymidine incorporation as a measure of population age in human diploid cells. , 1973, Experimental cell research.

[41]  D. Klein,et al.  Prostaglandins: stimulation of bone resorption in tissue culture. , 1970, Endocrinology.

[42]  L. Hayflick.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[43]  N. Sivasubramanian,et al.  Rapid Cycle Real-Time PCR — Methods and Applications , 2002, Springer Berlin Heidelberg.

[44]  A. Munshi,et al.  Neutrophil chemotaxis in Down syndrome and normal children to Actinobacillus actinomycetemcomitans. , 1998, The Journal of clinical pediatric dentistry.

[45]  G. Hunninghake,et al.  Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. , 1994, The Journal of clinical investigation.

[46]  H. McClure,et al.  Changes in cyclooxygenase metabolites in experimental periodontitis in Macaca mulatta. , 1989, Journal of periodontal research.

[47]  I. Ship,et al.  Periodontal disease in the institutionalized mongoloid. , 1977, Journal of oral medicine.

[48]  N. Johnson,et al.  Periodontal Disease in Mongols , 1963 .

[49]  G. Shklar,et al.  Oral aspects of mongolism , 1961 .